Home » Topics » BioWorld Science

BioWorld Science
RSS

Mitochondrial augmentation: a promising disease-modifying strategy for mitochondrial DNA disorders

Oct. 21, 2021

Alu RNA induces retinal pigment epithelium degeneration in geographic atrophy via the inflammasome

Oct. 21, 2021

Medshine Discovery describes new compounds for cancer

Oct. 21, 2021

Dongguan Hec New Drug Research and Development synthesizes new HBV antivirals

Oct. 21, 2021

Angiex presents new TM4SF1-targeting PROTACs

Oct. 21, 2021

Whole exome sequencing analysis identifies novel genes associated with osteoarthritis

Oct. 21, 2021

Chinese researchers disclose new ROS inhibitors

Oct. 21, 2021

Hutchison MediPharma patents new CSF1R inhibitors

Oct. 21, 2021

Role of de novo mutations in severe male infertility

Oct. 21, 2021

Discovery of broad-spectrum inhibitor of oncogenic BRAF dimerization

Oct. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...